catalog number :
MBS768321
products full name :
CX3CL1 Mouse Monoclonal
products short name :
[CX3CL1]
products name syn :
[FKN, NTT, SCYD1]
other names :
[CX3CL1; CX3CL1 protein; fractalkine; C-X3-C motif chemokine ligand 1; CX3CL1 protein]
products gene name :
[CX3CL1]
other gene names :
[CX3CL1; CX3CL1; NTN; NTT; CXC3; CXC3C; SCYD1; ABCD-3; C3Xkine; fractalkine; neurotactin]
uniprot entry name :
Q6I9S9_HUMAN
reactivity :
Human; other species are not tested.
specificity :
Please decide the specificity by homology.
purity :
> 95% as determined by SDS-PAGE/Protein A+G purification
form :
Liquid; PBS with 0.02% sodium azide and 50% glycerol pH 7.3
storage stability :
Store at -20°C for 24 months. (Avoid repeated freeze / thaw cycles.)
tested application :
ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC)
app notes :
Recommended dilution: WB: 1:500-1:2000; IHC: 1:50-1:500
image1 heading :
Immunohistochemistry (IHC)
image2 heading :
Western Blot (WB)
other info1 :
Immunogen: Chemokine (C-X3-C motif) ligand 1
products description :
Acts as a ligand for both CX3CL1 and integrins. Binds to CX3CR1(PubMed:23125415, PubMed:9931005, PubMed:21829356). Binds to integrins ITGAV:ITGB3 and ITGA4:ITGB1. Can activate integrins in both a CX3CR1-dependent and CX3CR1-independent manner. In the presence of CX3CR1, activates integrins by binding to the classical ligand-binding site(site 1) in integrins. In the absence of CX3CR1, binds to a second site(site 2) in integrins which is distinct from site 1 and enhances the binding of other integrin ligands to site 1(PubMed:23125415, PubMed:24789099). The soluble form is chemotactic for T-cells and monocytes and not for neutrophils. The membrane-bound form promotes adhesion of those leukocytes to endothelial cells. May play a role in regulating leukocyte adhesion and migration processes at the endothelium(PubMed:9024663, PubMed:9177350).
ncbi acc num :
CAG33707.1
ncbi pathways :
Chemokine Receptors Bind Chemokines Pathway (1269547); Chemokine Signaling Pathway (99051); Chemokine Signaling Pathway (96864); Class A/1 (Rhodopsin-like Receptors) Pathway (1269545); Cytokine-cytokine Receptor Interaction Pathway (83051); Cytokine-cytokine Receptor Interaction Pathway (460); Direct P53 Effectors Pathway (137939); GPCR Ligand Binding Pathway (1269544); Peptide Ligand-binding Receptors Pathway (1269546); Signal Transduction Pathway (1269379)